Sana Biotechnology Inc reports results for the quarter ended in March - Earnings Summary

Sana Biotechnology

11/05/2022 20:07

* Sana Biotechnology Inc  SANA.OQ  reported a quarterly
adjusted
loss of 17 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 47 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Sana Biotechnology Inc's reported EPS for the quarter was
a loss
of 17 cents​.
    * The mean earnings estimate of analysts had risen by
about 38.5%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Sana Biotechnology Inc shares had fallen by 24.5% this
quarter and lost 59.7% so far this year.
    * The company reported a quarterly loss of $31.45 million.
    * Wall Street's median 12-month price target for Sana
Biotechnology Inc is $17.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 11 at 07:07 p.m.  ​All
figures in US dollars unless otherwise stated